David Gallo - Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto

基本信息

Career Trajectory

Bio

David Gallo currently works at the Department of Biochemistry, University of Toronto. David does research in Molecular Biology. Their most recent publication is 'Rad5 Recruits Error-Prone DNA Polymerases for Mutagenic Repair of ssDNA Gaps on Undamaged Templates'.

Research Interests

Papers共 31 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Haineng Xu,Erin George,David Gallo,Sergey Medvedev, Xiaolei Wang,Rosie Kryczka,Marc L Hyer,Jimmy Fourtounis,Rino Stocco,Elia Aguado-Fraile,Adam Petrone,Shou Yun Yin, Ariya Shiwram,Matthew Anderson,Hyoung Kim,Fang Liu,C Gary Marshall,Fiona Simpkins

Research square (2024)

Cited0Views0WOSBibtex

Supplementary Figures from Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy

Courtney H. Coschi,Charles A. Ishak,David Gallo,Aren Marshall,Srikanth Talluri, Jianxin Wang,Matthew J. Cecchini,Alison L. Martens, Vanessa Percy,Ian Welch,Paul C. Boutros,Grant W. Brown,Frederick A. Dick

crossref（2023）

Cited0Views0Bibtex

Abstract A023: Preclinical Development of PKMYT1 and WEE1 Inhibitor Combinations

David Gallo,Fenil Shah,Rino Stocco,Prasamit Baruah,Jimmy Fourtounis,Rosie Kryczka,Marc L Hyer,Anne Roulston,C Gary Marshall,Michal Zimmermann,Stephen Morris,Michael Zinda

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

Cited0Views0Bibtex

Abstract B057: Preclinical Development of PKMYT1 and ATR Inhibitor Combinations

David Gallo,Marc L. Hyer,Giovanni Martino, Adam Pertrone,Elia Aguado-Fraile,Rosie Kryczka,Jimmy Fourtounis,Rino Stocco,Stephen J. Morris,C. Gary Marshall,Anne Roulston,Michael Zinda,Michal Zimmermann

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

Cited0Views0Bibtex

Abstract C163: KRAS Alterations Combined with TP53 Mutations As Novel Synthetic Lethal Genomic Lesions for PKMYT1 Inhibition

Marc L. Hyer,Jimmy Fourtounis,David A. Gallo,Vivek Bhaskaran,Rino Stocco,Rosie Kryczka, Sai Save, Helen E. Burston,Olivier Nicolas,Stephen Morris,Anne Roulston,Jordan T.F. Young,Michal Zimmermann,C. Gary Marshall,Artur Veloso,Elia Aguado-Fraile

Molecular cancer therapeuticsno. 12_Supplement (2023): C163-C163

Cited0Views0Bibtex

CDK12 Loss Leads to Replication Stress and Sensitivity to Combinations of the ATR Inhibitor Camonsertib (RP-3500) with PARP Inhibitors

J. Setton,D. Gallo,D. Glodzik, B. Kaiser, S. Braverman, T. Ubhi, S. Fournier,P. Selenica, N. Laterreur,A. Roulston, G. Brown, S. Morris,J. Reis-Filho, M. Zimmermann

European journal of cancer（2022）

Cited0Views0Bibtex

The PKMYT1 Inhibitor RP-6306 Has Synergistic Efficacy with Carboplatin in CCNE1 Amplified Tumor Models

J. Fourtounis,D. Gallo,A. Roulston,R. Stocco, G. Martino, S. Fournier, E. Aguado, R. Kryczka,V. Bhaskaran, S. Morris,C. G. Marshall

European journal of cancer（2022）

Cited0Views0Bibtex

RP-6306, a novel PKMYT1 inhibitor, demonstrates synthetic lethality as monotherapy and in combination with gemcitabine in CCNE1 amplified cancer cells

Jimmy Fourtounis, John Martino,Rino Stocco,Prasamit Baruah,Nicole Duffy,David Gallo,Sarah Fournier, JingJing Li,Li Li,Elia Aguado,Adam Petrone,Anne Roulston,Yael Mamane,Stephen Morris,Janek Szychowski,Robert Papp,Mike Zinda,C. Gary Marshall

CANCER RESEARCH（2022）

Cited0Views0Bibtex

Abstract 5650: RP-6306, a Novel PKMYT1 Inhibitor, Demonstrates Synthetic Lethality As Monotherapy and in Combination with Gemcitabine in CCNE1 Amplified Cancer Cells

Jimmy Fourtounis, John Martino,Rino Stocco,Prasamit Baruah,Nicole Duffy,David Gallo,Sarah Fournier, JingJing Li, Li,Elia Aguado,Adam Petrone,Anne Roulston,Yael Mamane,Stephen Morris,Janek Szychowski,Robert Papp,Mike Zinda,C. Gary Marshall

Cancer research（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn